Researchers conducted a post hoc analysis to learn whether or not the length of time it took to attain initial viral suppression is related to sustained virologic response (SVR) rates for patients receiving the so-call 3D treatment, with or without ribavirin.
Insurance companies are denying members coverage to expensive drugs, like Harvoni, and those infected with HCV are filing lawsuits.
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, discusses the importance of new medications to treat hepatitis C.
A new project aims to develop and assess new hepatitis C vaccination strategies in an effort to improve treatment.
Researchers offer more insight on the role of IFN-I and find a potential therapeutic target that may be able to protect against chronic viral infections.
New research from the Medical University of Vienna has made a connect between blood infections and an increased risk of arteriosclerosis.
In a phase 3 clinical trial, Japanese patients with chronic hepatitis C (HCV) infection without liver cirrhosis were able to achieve high sustained viral response rates after taking an investigational HCV drug from AbbVie.
Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, explains why it’s important for individuals to know that they are infected with hepatitis C, although they may be asymptomatic.
A new biotechnology company, Vir Biotechnology, is gunning for bear in the fight against infectious diseases and boasting a roster of heavy hitters in the industry.
Despite the fact that an increasingly large portion of the hepatitis C (HCV)-infected population successfully achieves a cure for the infection, called sustained viral response (SVR), this population still deals with increased mortality rates.
Harvoni has been added to Express Script’s formulary and will be available from the company’s Hepatitis Cure Value Program.
The European Medicines Agency (EMA) released guidelines recommending screening for hepatitis B in patients who are infected with hepatitis C prior to starting treatment with direct-acting antivirals.
Researchers from Purdue University have discovered a connection between hepatitis B (HBV) infection and liver cancer.
Why do more HCV-infected immigrants, rather than non-immigrants, end up hospitalized for liver problems? Inadequate screening and longer infection duration are likely reasons.
In a review article, researchers share current understanding of the pathogenesis of type IV T cell-dependent immune-mediated ADRs and review the evidence for diagnostics for T cell-mediated ADRs.
Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.
Researchers have not been able to develop a vaccine for hepatitis C, which causes 700,000 deaths around the world annually, and now, a new study shows why developing a vaccine for the virus has been so difficult.
A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.
The FDA has released a warning on the risk of reactivation of hepatitis B virus in some patients receiving direct-action antivirals to treat hepatitis C infection.
Researchers at the University of North Carolina at Chapel Hill have found out how hepatitis A causes acute liver injury.
Hepatitis A cases have been reported throughout at least nine different US states and the number of cases continue to rise.
Researchers from Nanjing Biopoint have made a breakthrough when it comes to fighting HIV through the development of a product that uses certain material when collecting blood samples that can separate the plasma from the rest of the blood, allowing the sample to be safely sent to a testing center.
Researchers from the Copenhagen University Hospital of Denmark find that individuals who are hospitalized with infections have an increased risk of suicide ideation and death; individuals infected with hepatitis and HIV or AIDS have the highest risk of suicide-related death.
